Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Puma Biotechnology (PBYI) Assets Average: 2017-2025

Historic Assets Average for Puma Biotechnology (PBYI) over the last 9 years, with Sep 2025 value amounting to $198.9 million.

  • Puma Biotechnology's Assets Average fell 6.56% to $198.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $198.9 million, marking a year-over-year decrease of 6.56%. This contributed to the annual value of $221.9 million for FY2024, which is 1.93% down from last year.
  • Latest data reveals that Puma Biotechnology reported Assets Average of $198.9 million as of Q3 2025, which was up 1.71% from $195.5 million recorded in Q2 2025.
  • In the past 5 years, Puma Biotechnology's Assets Average ranged from a high of $259.3 million in Q2 2021 and a low of $195.5 million during Q2 2025.
  • Over the past 3 years, Puma Biotechnology's median Assets Average value was $209.2 million (recorded in 2023), while the average stood at $208.0 million.
  • As far as peak fluctuations go, Puma Biotechnology's Assets Average grew by 9.22% in 2021, and later fell by 23.97% in 2022.
  • Puma Biotechnology's Assets Average (Quarterly) stood at $226.4 million in 2021, then dropped by 7.08% to $210.4 million in 2022, then grew by 3.16% to $217.1 million in 2023, then dropped by 0.02% to $217.0 million in 2024, then fell by 6.56% to $198.9 million in 2025.
  • Its Assets Average stands at $198.9 million for Q3 2025, versus $195.5 million for Q2 2025 and $204.8 million for Q1 2025.